WallStreetZenWallStreetZen

NASDAQ: GENE
Genetic Technologies Ltd Earnings & Revenue

OverviewEarnings
DividendOwnership

GENE past revenue growth

How has GENE's revenue growth performed historically?
Company
-3.27%
Industry
0.14%
Market
16.96%
GENE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GENE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GENE's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GENE earnings and revenue history

Current Revenue
$5.8M
Current Earnings
-$8.7M
Current Profit Margin
-150%

GENE Return on Equity

Current Company
-160.9%
Current Industry
-24%
Current Market
188%
GENE's Return on Equity (-160.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GENE announces earnings.

GENE Return on Assets

Current Company
-105.5%
Current Industry
6.7%
GENE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GENE Return on Capital Employed

Current Company
-252.2%
Current Industry
11.6%

GENE vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GENE$5.55MN/A-$8.33M+136.93%N/A
ISPC$9.93M-$9.02M-$11.10M+23.28%N/A
NDRA$0.00-$9.78M-$10.06M-100.00%N/A
APDN$9.00M-$5.89M-$7.29M+16.79%N/A
MDXH$70.19M-$20.47M-$43.10M+56.22%N/A
View Top Diagnostic & Research Stocks

Genetic Technologies Earnings & Revenue FAQ

What were GENE's earnings last quarter?

On Invalid Date, Genetic Technologies (NASDAQ: GENE) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Genetic Technologies earnings for the quarter were N/A. In the same quarter last year, Genetic Technologies's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Genetic Technologies stock.

What was GENE's earnings growth in the past year?

As of Q2 2024, Genetic Technologies's earnings has grown year over year. Genetic Technologies's earnings in the past year totalled -$8.33 million.

What was GENE's revenue last quarter?

On Invalid Date, Genetic Technologies (NASDAQ: GENE) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Genetic Technologies's revenue was N/A.

What was GENE's revenue growth in the past year?

As of Q2 2024, Genetic Technologies's revenue has grown -3.27% year over year. This is 3.42 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 0.14%. Genetic Technologies's revenue in the past year totalled $5.55 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.